The present invention provides compounds of formula (I), their use as aninhibitor of ap53-MDM2 interaction as well as pharmaceutical compositions comprising saidcompounds offormula (I) wherein n, m, p, s, t, R1, R2, A and Z have defined meanings.(see formula I)